Holen Sie sich die Stockscreener-App
174.12
0.88%
-1.55
Vorhandelsmarkt:
174.01
-0.11
-0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$175.67
Offen:
$176.03
24-Stunden-Volumen:
2.28M
Relative Volume:
0.93
Marktkapitalisierung:
$78.56B
Einnahmen:
$9.15B
Nettoeinkommen (Verlust:
$2.43B
KGV:
32.73
EPS:
5.32
Netto-Cashflow:
$2.31B
1W Leistung:
+0.82%
1M Leistung:
+4.95%
6M Leistung:
-6.03%
1J Leistung:
-11.23%
1-Tages-Spanne:
$174.00
$177.40
1-Wochen-Bereich:
$168.28
$177.40
52-Wochen-Spanne:
$144.80
$200.53
Zoetis Inc Stock (ZTS) Company Profile
Firmenname
Zoetis Inc
Sektor
Telefon
973-822-7000
Adresse
10 SYLVAN WAY, PARSIPPANY, NJ
Vergleichen Sie ZTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
174.12 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.61 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.51 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.29 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
150.51 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-12 | Bestätigt | Stifel | Buy |
| 2023-12-19 | Fortgesetzt | Jefferies | Buy |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-08-14 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-08-12 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-09-09 | Eingeleitet | Goldman | Buy |
| 2019-07-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2019-05-03 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-10-15 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Herabstufung | Stifel | Buy → Hold |
| 2018-08-03 | Bestätigt | Stifel | Buy |
| 2018-04-19 | Bestätigt | Citigroup | Buy |
| 2018-03-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Bestätigt | Stifel | Buy |
| 2018-01-04 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
Mirae Asset Global Investments Co. Ltd. Grows Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Stock Position Increased by Calamos Wealth Management LLC - MarketBeat
Stock Yards Bank & Trust Co. Cuts Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Alliance Wealth Advisors LLC UT Buys 3,700 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis sets $0.50 per share dividend for Q2 2025 - MSN
William Blair Issues Negative Estimate for Zoetis Earnings - MarketBeat
Opportunities to Improve Chick Health: Interview with Tarsicio Villalobos from Zoetis at IPPE 2025 - aviNews International
Zoetis Announces Q2 2025 Dividend Payment - TipRanks
Zoetis Declares Second Quarter 2025 Dividend - The Bakersfield Californian
ZTS: 3 Pet Industry Stocks Profiting from Animal Lovers - StockNews.com
Veterinary Wound Cleansers Market Share & Growth Forecast - GlobeNewswire
Veterinary Wound Cleansers Market Share & Growth Forecast Report 2025-2030, with Elanco, Vetoquinol, Virbac, Innovacyn, Axio Biosolutions, Neogen, Pet Natural Remedies, Zoetis and More - Yahoo Finance
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Legacy CG LLC Buys New Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
YANKCOM Partnership Purchases Shares of 2,904 Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Stock Holdings Increased by Choreo LLC - MarketBeat
Yousif Capital Management LLC Sells 3,137 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Animal Parasiticides Market Witness Growth: Size, Share, - openPR
Librela™ update: Changes to Librela label from Zoetis - AAHA
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Nvwm LLC Grows Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Pet Vaccines Market Growth to Accelerate in Forecast Period - openPR
Avitas Wealth Management LLC Buys 6,828 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Windward Capital Management Co. CA Lowers Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Ninety One UK Ltd Raises Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Sold by Boston Trust Walden Corp - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Sold by Tritonpoint Wealth LLC - MarketBeat
Zoetis announces updated label for Librela - TipRanks
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain - Vet Candy
Updated Zoetis label for Librela ‘a relief,’ says Piper Sandler - MSN
Zoetis Adds Warnings to Label for Dog Pain Drug - MSN
Zoetis updates Librela label after post-approval data - MSN
Zoetis Adds Warnings to Label for Dog-Pain Drug - The Wall Street Journal
Zoetis Inc. (NYSE:ZTS) Holdings Lifted by E. Ohman J or Asset Management AB - MarketBeat
Zoetis Updates Label on Drug for Treatment of Canine Osteoarthritis -February 04, 2025 at 08:48 am EST - Marketscreener.com
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Calamos Advisors LLC - MarketBeat
Zoetis updates Librela label after post-approval data By Investing.com - Investing.com UK
(bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain - Business Wire
abrdn plc Cuts Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Spire Wealth Management Sells 5,744 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Cibc World Market Inc. Purchases 49,774 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Institute for Wealth Management LLC. Has $330,000 Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Sivik Global Healthcare LLC Buys New Shares in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Turtle Creek Wealth Advisors LLC Decreases Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
SteelPeak Wealth LLC Takes Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Stifel maintains Zoetis stock Buy rating, $180 target amid Librela view - MSN
Willis Investment Counsel Takes $7.53 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
DAVENPORT & Co LLC Increases Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
New England Research & Management Inc. Has $4.06 Million Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Morgan Stanley Lowers Zoetis (NYSE:ZTS) Price Target to $243.00 - MarketBeat
Pacer Advisors Inc. Purchases 5,790 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Finanzdaten der Zoetis Inc-Aktie (ZTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):